documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
10 rows where docket_id = "FDA-2004-E-0266" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 10
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2004-E-0266-0010 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | United States Patent and Trademark Office - Letter With Attached Certificate | Other | Letter(s) | 2011-10-26T04:00:00Z | 2011 | 10 | 2011-10-26T04:00:00Z | 2011-10-26T14:08:57Z | 0 | 0 | 0900006480f5cc06 | ||
| FDA-2004-E-0266-0009 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | U.S. Patent & Trademark Office to Connolly Bove Lodge & Hutz LLP - Notice of Final Determinaton | Other | LET-Letter | 2010-12-27T05:00:00Z | 2010 | 12 | 2010-12-27T05:00:00Z | 2013-07-27T23:40:38Z | 0 | 0 | 0900006480bc087f | ||
| FDA-2004-E-0266-0008 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | FDA/CDER to US Patent and Trademark Office - Letter | Other | LET-Letter | 2010-03-04T05:00:00Z | 2010 | 3 | 2010-03-04T05:00:00Z | 2013-07-27T23:10:37Z | 0 | 0 | 0900006480ab3c58 | ||
| FDA-2004-E-0266-0007 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | Determination of Regulatory Review Period for Purposes of Patent Extension; SENSIPAR | Notice | N-Notice | 2009-05-14T04:00:00Z | 2009 | 5 | 2009-05-14T04:00:00Z | 2009-07-14T03:59:59Z | 2009-05-15T07:33:12Z | E9-11219 | 0 | 0 | 0900006480991d0a |
| FDA-2004-E-0266-0006 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | FDA/CDER to the U.S. Patent and Trademark Office - Letter | Other | LET-Letter | 2009-04-28T04:00:00Z | 2009 | 4 | 2009-04-28T04:00:00Z | 2009-04-28T18:35:49Z | 0 | 0 | 090000648096dc16 | ||
| FDA-2004-E-0266-0005 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | Patent Term Extension Application - Attachment A | Supporting & Related Material | APP-Application | 2009-04-28T04:00:00Z | 2009 | 4 | 2009-04-28T15:05:05Z | 0 | 0 | 09000064804721c8 | |||
| FDA-2004-E-0266-0003 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | NPS Pharmaceticals Inc. and Brigham and Women's Hospital - Patent Term Extension Application | Other | APP-Application | 2008-10-23T04:00:00Z | 2008 | 10 | 2008-10-23T04:00:00Z | 2013-07-27T20:49:47Z | 0 | 0 | 09000064804721c7 | ||
| FDA-2004-E-0266-0004 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | U.S. Patent and Trademark Office to FDA - Letter | Other | LET-Letter | 2008-10-23T04:00:00Z | 2008 | 10 | 2008-10-23T04:00:00Z | 2008-10-23T13:20:00Z | 0 | 0 | 0900006480774637 | ||
| FDA-2004-E-0266-0002 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | FDA/CDER to US Patent and Trademark Office - Letter | Other | LET-Letter | 2004-10-22T04:00:00Z | 2004 | 10 | 2009-04-28T14:32:31Z | 0 | 0 | 09000064804721d1 | |||
| FDA-2004-E-0266-0001 | FDA | Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 | U.S. Patent & Trademark Office to FDA/CDER - Letter | Other | LET-Letter | 2004-09-28T04:00:00Z | 2004 | 9 | 2009-04-28T14:30:53Z | 0 | 0 | 09000064804721c4 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);